Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Des Devel Ther. 2010 Dec 22;5:9-26. doi: 10.2147/DDDT.S6959.

Current progress in the development of a prophylactic vaccine for HIV-1.

Author information

1
Department of Medicine, The Gene Therapy Center, University of Alabama at Birmingham, 35294, USA.

Abstract

Since its discovery and characterization in the early 1980s as a virus that attacks the immune system, there has been some success for the treatment of human immunodeficiency virus-1 (HIV-1) infection. However, due to the overwhelming public health impact of this virus, a vaccine is needed urgently. Despite the tireless efforts of scientist and clinicians, there is still no safe and effective vaccine that provides sterilizing immunity. A vaccine that provides sterilizing immunity against HIV infection remains elusive in part due to the following reasons: 1) degree of diversity of the virus, 2) ability of the virus to evade the hosts' immunity, and 3) lack of appropriate animal models in which to test vaccine candidates. There have been several attempts to stimulate the immune system to provide protection against HIV-infection. Here, we will discuss attempts that have been made to induce sterilizing immunity, including traditional vaccination attempts, induction of broadly neutralizing antibody production, DNA vaccines, and use of viral vectors. Some of these attempts show promise pending continued research efforts.

KEYWORDS:

AIDS; HIV; prophylactic vaccine; sterilizing immunity; viral vectors

PMID:
21267356
PMCID:
PMC3023272
DOI:
10.2147/DDDT.S6959
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Support Center